Par Pharm Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PAR PHARM INC, and what generic alternatives to PAR PHARM INC drugs are available?
PAR PHARM INC has one approved drug.
There is one US patent protecting PAR PHARM INC drugs. There are seven tentative approvals on PAR PHARM INC drugs.
There are nine patent family members on PAR PHARM INC drugs in eight countries.
Drugs and US Patents for Par Pharm Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Par Pharm Inc | ANTIZOL | fomepizole | INJECTABLE;INJECTION | 020696-001 | Dec 4, 1997 | DISCN | Yes | No | 7,553,863 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Par Pharm Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Mexico | 2007013118 | ⤷ Sign Up |
South Korea | 20080000660 | ⤷ Sign Up |
Canada | 2605413 | ⤷ Sign Up |
Japan | 2008538560 | ⤷ Sign Up |
Japan | 5378788 | ⤷ Sign Up |
Australia | 2006240490 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.